$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
帕博西尼(哌柏西利)有望治疗急性髓性白血病
2025-10-19 11:44:20
Check Details
达沙替尼和尼罗替尼治疗效果对比
2025-10-19 11:44:20
Check Details
达沙替尼获欧盟委员会批准用于儿童白血病
2025-10-19 11:44:20
Check Details
慢粒白血病服用达沙替尼治疗失败怎么办
2025-10-19 11:44:20
Check Details
达沙替尼的服用剂量和作用机制
2025-10-19 11:44:20
Check Details
达沙替尼联合其他药物治疗时的服用剂量
2025-10-19 11:44:20
Check Details
不同时期的白血病患者服用达沙替尼的剂量是不一样的
2025-10-19 11:44:20
Check Details
治疗白血病时服用达沙替尼过量怎么办?
2025-10-19 11:44:20
Check Details
达沙替尼的作用机制和结构
2025-10-19 11:44:20
Check Details
慢粒性白血病病变期之慢性期
2025-10-19 11:44:20
Check Details
慢粒性白血病病变期之加速期
2025-10-19 11:44:20
Check Details
慢粒性白血病病变期之急变期
2025-10-19 11:44:20
Check Details
1
2
...
133
134
135
136
137
138
139
...
935
936
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tafasitamab and Lenalidomide Combination Therapy Guide
2
Pirtobrutinib (Jaypirca) Medication Guide: Overcoming BTK Resistance & Safety Management
3
Gilteritinib Professional Medication Guide & Dosage Management
4
Pirtobrutinib: A Novel Non-Covalent BTK Inhibitor for Relapsed Hematologic Malignancies
5
Clinical Application and Safety Monitoring of Revumenib (Menin Inhibitor) in Acute Leukemia
6
Ixazomib & Pomalidomide in Multiple Myeloma: Mechanisms & Clinical Insights
7
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
8
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
9
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
10
Plerixafor Complete Side Effect Guide: Adverse Reaction Classification and Professional Management
11
Lusutrombopag Efficacy, Dosage and Storage Instructions
12
Anagrelide (Agrylin): Managing ET-Related Thrombocytosis